PASSIFLORA INCARNATA

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: PASSIFLORA INCARNATA
Generic name: PASSIFLORA INCARNATA
Manufacturer: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
Product type: HUMAN OTC DRUG
SPL set ID: 3c2a9fa1-0d7a-48db-ac73-f6e74d0aba98
SPL ID: cf04ac6b-3b6e-fc24-e053-2995a90a56d1
Version: 4
Effective date: 2021-10-23
Source export date: 2026-11-06
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/39f3c0903357a80632a5484c9d6a804272f4b297080aa9c5a01a84db133f7a03/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:57:26

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 23 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		PASSIFLORA INCARNATA	openfda.brand_name
generic name		PASSIFLORA INCARNATA	openfda.generic_name
manufacturer name		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	openfda.manufacturer_name
ndc	package	15631-0331-5	openfda.package_ndc
ndc	package	15631-0331-6	openfda.package_ndc
ndc	package	15631-0331-3	openfda.package_ndc
ndc	package	15631-0331-0	openfda.package_ndc
ndc	package	15631-0331-4	openfda.package_ndc
ndc	package	15631-0331-1	openfda.package_ndc
ndc	package	15631-0331-7	openfda.package_ndc
ndc	package	15631-0331-2	openfda.package_ndc
ndc	product	15631-0331	openfda.product_ndc
ndc11	package	15631033104	derived:openfda.package_ndc
ndc11	package	15631033105	derived:openfda.package_ndc
ndc11	package	15631033102	derived:openfda.package_ndc
ndc11	package	15631033107	derived:openfda.package_ndc
ndc11	package	15631033103	derived:openfda.package_ndc
ndc11	package	15631033100	derived:openfda.package_ndc
ndc11	package	15631033101	derived:openfda.package_ndc
ndc11	package	15631033106	derived:openfda.package_ndc
spl id		cf04ac6b-3b6e-fc24-e053-2995a90a56d1	id
spl set id		3c2a9fa1-0d7a-48db-ac73-f6e74d0aba98	set_id
unii		CLF5YFS11O	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are preganant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.